Health

Resilience in reputation has always been important. But in a decade which has already seen a global pandemic, a decline in democracy,...

Pharma and biotech, patients, payers, regulators and HTA agencies gathered at the World Evidence, Pricing and Access Congress in March...

Mental health has been on the margins of the European health debate for a long time. Yet, one in six people in the EU, or more than 84...

Nanomedicine is a complex and diverse term, encompassing the use of nanomaterials for the diagnosis, control, prevention, and...

“Saving our planet is now a communications challenge”.
Sir David Attenborough

We set out to test a hypothesis from Sir...

Hanover has today announced that former NHS England medicines adviser Malcolm Qualie has joined Hanover as a Senior Advisor focused on...

With the war in Ukraine and rising energy prices stirring the beginnings of an anti-green backlash, it’s never been more important to...

For all organisations, the need to understand the diversity, equity and inclusion (DE&I) agenda within their workplace – and...

The promise of innovative technologies is significant and is welcomed globally. The prospect of new therapies that could save and...

What should your pharma company talk about for the next twelve months?

It’s a question that many communications and public...

In 2017, former President of the European Commission Jean-Claude Juncker presented his White Paper on the Future of Europe:...

Many years in the making, the first CVDPREVENT audit report, published recently, gives a detailed snapshot of how those with...